Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Why are some individuals resistant to the cardioprotective effects of aspirin? Could it be thromboxane A2?

× No keyword cloud information.

15 in total

Review 1. A review of antiplatelet drugs, coronary artery diseases and cardiopulmonary bypass.

Authors: Yajun Ren; Kirti Patel; Terry Crane
Journal: J Extra Corpor Technol Date: 2010-06

2. The variability of platelet response to aspirin and clopidogrel: revisiting the Caprie, Cure, Credo, and Match trials.

Authors: Robert I Myers
Journal: Proc (Bayl Univ Med Cent) Date: 2005-10

3. Daily administration of the TP receptor antagonist terutroban improved endothelial function in high-cardiovascular-risk patients with atherosclerosis.

Authors: Pierre-François Lesault; Laurent Boyer; Gabriel Pelle; Ala Covali-Noroc; Dominique Rideau; Servais Akakpo; Emmanuel Teiger; Jean-Luc Dubois-Randé; Serge Adnot
Journal: Br J Clin Pharmacol Date: 2011-06 Impact factor: 4.335

Review 4. Aspirin resistance, an emerging, often overlooked, factor in the management of patients with coronary artery disease.

Authors: Amgad N Makaryus
Journal: Clin Cardiol Date: 2006-04 Impact factor: 2.882

5. Aspirin resistance: Fact or fiction? A point of view.

Authors: Jawahar L Mehta; Bhavna Mohandas
Journal: World J Cardiol Date: 2010-09-26

Review 6. Do some inhibitors of COX-2 increase the risk of thromboembolic events?: Linking pharmacology with pharmacoepidemiology.

Authors: David W J Clark; Deborah Layton; Saad A W Shakir
Journal: Drug Saf Date: 2004 Impact factor: 5.606

7. Statins but not aspirin reduce thrombotic risk assessed by thrombin generation in diabetic patients without cardiovascular events: the RATIONAL trial.

Authors: Alejandro Macchia; Nicolás Laffaye; Pablo D Comignani; Elena Cornejo Pucci; Cecilia Igarzabal; Alejandra S Scazziota; Lourdes Herrera; Javier A Mariani; Julio C Bragagnolo; Hugo Catalano; Gianni Tognoni; Antonio Nicolucci
Journal: PLoS One Date: 2012-03-28 Impact factor: 3.240

8. Assessment of aspirin resistance varies on a temporal basis in patients with ischaemic heart disease.

Authors: A R Muir; M F McMullin; C Patterson; P P McKeown
Journal: Heart Date: 2008-08-12 Impact factor: 5.994

9. Aspirin resistance.

Authors: Khaled Mansour; Ali T Taher; Khaled M Musallam; Samir Alam
Journal: Adv Hematol Date: 2009-04-14

10. Urinary 11-dehydro-thromboxane B2 levels are associated with vascular inflammation and prognosis in atherosclerotic cardiovascular disease.

Authors: Nan Wang; Kimberly C Vendrov; Brian P Simmons; Robert N Schuck; George A Stouffer; Craig R Lee
Journal: Prostaglandins Other Lipid Mediat Date: 2017-11-16 Impact factor: 3.072